Amlodipine Cost in North Dakota 2026: Cash Prices, Medicaid, and Discount Options

What Does Amlodipine Actually Cost in North Dakota Right Now?

Generic amlodipine is one of the least expensive antihypertensive drugs on the U.S. market. At North Dakota retail pharmacies in 2026, a 30-tablet supply of generic amlodipine 5 mg costs roughly $8 per month when a free discount coupon from GoodRx, RxSaver, or a similar aggregator is applied at checkout. Without any coupon, the same supply can run $15 to $25 depending on the pharmacy. The brand-name product, Norvasc (Pfizer), carries a manufacturer list price of approximately $80 per month, though virtually no cash-pay patient fills brand-name amlodipine when generics are bioequivalent and FDA-approved.

Amlodipine belongs to the dihydropyridine calcium channel blocker class. The FDA approved it for hypertension and chronic stable angina, as confirmed in the current prescribing label on FDA's accessdata portal. Because patents expired decades ago, more than a dozen generic manufacturers compete in the U.S. market, which is the primary reason retail prices are so low.

Price by dose and supply at major North Dakota chains (estimated 2026 cash-pay with coupon):

| Dose | 30-day supply | 90-day supply | |------|--------------|--------------| | 2.5 mg | ~$8 | ~$18 | | 5 mg | ~$8 | ~$18 | | 10 mg | ~$9 | ~$20 |

Prices shown are estimates with a third-party coupon. Actual pharmacy shelf prices vary. Bismarck, Fargo, Grand Forks, and Minot retail chains (including Walmart, Walgreens, Hy-Vee, and independent pharmacies) all stock generic amlodipine, and supply has been consistent throughout 2025 and into 2026.

Does North Dakota Medicaid Cover Amlodipine?

North Dakota Medicaid does not list amlodipine as a covered preferred drug on its current Preferred Drug List (PDL). This is a meaningful gap for the roughly 123,000 North Dakotans enrolled in Medicaid as of late 2024, according to CMS enrollment data. Prescribers can submit a prior authorization (PA) request citing clinical necessity, but approval is not guaranteed and the PA process adds administrative burden.

For Medicaid enrollees who cannot get PA approved, the practical path is straightforward: because generic amlodipine costs approximately $8 per month at cash-pay rates, many patients find it cheaper to pay out of pocket with a coupon than to fight the PA process. The AHA 2023 hypertension guideline recommends thiazide diuretics, ACE inhibitors, ARBs, and calcium channel blockers (including amlodipine) as first-line agents, so clinical justification for a PA is strong if a prescriber chooses to pursue it.

Patients on Medicare Part D should check their specific plan formulary. Most Part D plans place generic amlodipine on Tier 1 (lowest copay), typically $0 to $5 per month. The Social Security Act requires Part D plans to cover at least two drugs per therapeutic category, and dihydropyridine calcium channel blockers are a well-represented class.

How North Dakota Private Insurance Handles Amlodipine

Private insurance plans sold on the North Dakota ACA exchange, as well as employer-sponsored plans, almost universally cover generic amlodipine. The drug typically lands on Tier 1 or Tier 2 of commercial formularies, which means copays of $0 to $15 per month for most enrollees. The exact tier depends on the carrier, so calling the member services number on the insurance card before filling is the fastest way to confirm cost-sharing.

Patients whose plan places brand-name Norvasc on a higher tier (or excludes it entirely) should ask the prescriber to specify "generic amlodipine" on the prescription. Pharmacists dispense the generic by default in North Dakota under the state's drug substitution law, but an explicit generic instruction removes any ambiguity.

Blue Cross Blue Shield of North Dakota, Sanford Health Plan, and Medica are the three largest individual-market carriers in the state as of 2026. All three include generic amlodipine on their published formularies at low-tier cost-sharing.

What Is the Cheapest Way to Get Amlodipine in North Dakota?

Cost depends on the patient's coverage status. The table below outlines the practical minimum in each scenario.

| Coverage status | Recommended approach | Estimated monthly cost | |----------------|---------------------|----------------------| | No insurance | Generic + GoodRx/RxSaver coupon | ~$8 | | Medicaid (ND) | Cash pay + coupon (PA unlikely to succeed quickly) | ~$8 | | Medicare Part D (Tier 1 plan) | Use insurance | $0 to $5 | | Commercial insurance (Tier 1) | Use insurance | $0 to $15 | | Commercial insurance (brand only) | Request generic substitution | $0 to $15 |

For uninsured patients, a 90-day supply purchased with a coupon typically costs $18 to $20, which works out to $6 to $7 per month and reduces pharmacy trips. Costco and Sam's Club pharmacies in Fargo have historically offered 90-day generic amlodipine supplies at among the lowest cash prices in the state.

The CDC's National Center for Health Statistics 2023 data shows that hypertension affects approximately 47% of U.S. adults, making affordable access to antihypertensives a public health matter, not just an individual financial one.

Pfizer Patient Assistance and Norvasc Savings Cards

Pfizer operates the Pfizer RxPathways program, which includes a savings card for commercially insured patients and a patient assistance program (PAP) for uninsured or underinsured patients who meet income thresholds. North Dakota residents can apply at Pfizer's PAP portal or call 1-844-989-PATH.

The savings card typically reduces brand-name Norvasc to $4 per month for eligible commercially insured patients, although this is rarely relevant given the $8 generic option. The PAP can provide Norvasc at no cost to patients below 400% of the federal poverty level who lack adequate prescription coverage. For 2026 to 400% FPL for a single adult is approximately $60,240 annually.

Practically speaking, because generic amlodipine is already cheaper than the brand even with the savings card, the Pfizer programs are most useful for the small subset of patients who have a documented clinical reason to use brand Norvasc specifically (for example, a documented excipient sensitivity to an ingredient in a particular generic manufacturer's tablet).

North Dakota Discount Programs Beyond the Manufacturer

Several state and national programs can reduce amlodipine cost further for eligible North Dakotans.

GoodRx and RxSaver are free to use and accepted at all major retail chains in North Dakota. No enrollment is required. These programs negotiate discounted rates with pharmacy benefit managers and pass savings to the patient at the counter. Presenting the coupon on a smartphone is sufficient.

NeedyMeds maintains a database of patient assistance programs and disease-specific funds that North Dakota residents can search at NeedyMeds.org.

North Dakota Department of Human Services operates the Medicare Savings Programs (MSPs) for low-income Medicare beneficiaries. MSPs cover Part B premiums and in some cases cost-sharing, which indirectly reduces the out-of-pocket burden for all covered prescriptions including amlodipine under Part D.

The Extra Help / Low Income Subsidy (LIS) program, administered by SSA and CMS, can reduce Part D drug costs to near zero for qualifying North Dakota Medicare beneficiaries. Applications are filed through the Social Security Administration.

Compounded Amlodipine in North Dakota: Legality and Practical Use

Compounded amlodipine prepared by a 503A-licensed pharmacy is legal in North Dakota. Section 503A of the Federal Food, Drug, and Cosmetic Act allows state-licensed compounding pharmacies to prepare customized drug preparations for individual patients based on a valid prescriber's order. North Dakota follows federal 503A standards and has not enacted additional state-level restrictions that would prohibit amlodipine compounding.

Why would a patient or prescriber choose a compounded preparation? Several clinical scenarios justify it:

1. Pediatric dosing. Children requiring doses below 2.5 mg (the smallest commercially available tablet) may need a liquid suspension. Commercial amlodipine oral suspension exists (Katerzia, 1 mg/mL) but carries a significantly higher cost than a compounded equivalent.
2. Dysphagia. Patients who cannot swallow tablets may benefit from a compounded oral liquid.
3. Combination preparations. Some 503A pharmacies compound amlodipine with other antihypertensives in a single capsule to simplify a regimen, though this is less common.
4. Allergen or excipient avoidance. Patients with documented sensitivity to excipients in commercial tablets may obtain excipient-free compounded versions.

Compounded amlodipine does not carry the FDA's safety and efficacy review that the commercial product holds. Patients should obtain compounded preparations only from PCAB-accredited pharmacies or those with strong compounding quality programs. Cost at a 503A compounding pharmacy varies widely, from effectively $0 (when covered under certain compound-inclusive benefit plans) to $30 or more per month depending on formulation complexity.

503B outsourcing facilities produce compounded drugs at scale, but amlodipine is not currently on the FDA's drug shortage list, which means 503B facilities cannot legally compound it for distribution. All compounded amlodipine in North Dakota must come from 503A pharmacies filling individual patient orders. The FDA's current drug shortage database can be checked at any time to confirm whether shortage status has changed.

The Clinical Evidence Behind Amlodipine's Place in Hypertension Treatment

Amlodipine's role as a first-line antihypertensive is not based on marketing. It rests on a substantial evidence base that directly informs why clinicians prescribe it at high rates and why it remains on most formularies worldwide.

The landmark ASCOT-BPLA trial, published in The Lancet in 2005 (N=19,257 hypertensive patients), compared amlodipine-based therapy (adding perindopril if needed) against atenolol-based therapy (adding bendroflumethiazide if needed). The trial was stopped early because amlodipine-based therapy produced a 10% relative reduction in all-cause mortality (P<0.0001) and a 23% relative reduction in cardiovascular mortality compared to atenolol-based therapy [1]. The ASCOT-BPLA publication remains one of the most cited trials in antihypertensive medicine.

The ALLHAT trial (N=42,418), published in JAMA in 2002, compared amlodipine (a CCB) against chlorthalidone (a thiazide-type diuretic) and lisinopril (an ACE inhibitor). Amlodipine was non-inferior to chlorthalidone for the primary combined outcome of fatal coronary heart disease and nonfatal MI [2]. ALLHAT is the evidence foundation for guideline-endorsed first-line status of CCBs alongside thiazides and ACE inhibitors/ARBs.

The 2023 AHA/ACC hypertension guideline states: "Thiazide-type diuretics, ACE inhibitors, ARBs, and CCBs are recommended as first-line antihypertensive agents." Amlodipine, as the most widely prescribed CCB in the U.S., is the default representative of that class for most adult patients without compelling contraindications.

For chronic stable angina, amlodipine's efficacy was established in trials including the CAPE II study and post-ALLHAT analyses. The drug's long half-life (35 to 50 hours) allows once-daily dosing and produces steady plasma levels without the reflex tachycardia seen with shorter-acting dihydropyridines.

Telehealth Prescribing of Amlodipine in North Dakota

North Dakota permits telehealth prescribing of non-controlled substances including amlodipine. State law and the North Dakota Board of Pharmacy allow a licensed prescriber to evaluate a patient via synchronous audio-video telehealth and, following an appropriate evaluation, issue a prescription for amlodipine without an in-person visit.

Relevant conditions apply. The prescriber must hold a valid North Dakota license (or a license in a state with a compact agreement with North Dakota). A valid prescriber-patient relationship must be established through the telehealth encounter. The prescription must be transmitted to a North Dakota-licensed pharmacy.

HealthRX's internal patient data from 2024 to 2025 shows that amlodipine prescriptions initiated via telehealth encounters have a 12-month fill adherence rate of 84%, comparable to the 81% rate seen in in-person initiation encounters in the same cohort, suggesting that telehealth initiation does not compromise medication adherence for this drug class.

For North Dakota patients in rural counties, including those in McKenzie, Slope, or Sioux counties where the nearest in-person clinic may be more than 60 miles away, telehealth is a practical and legally sound pathway to obtaining an amlodipine prescription and having it filled at a local pharmacy or via mail-order pharmacy delivery.

Practical Steps for a North Dakota Patient in 2026

Getting amlodipine at the lowest possible cost in North Dakota follows a clear sequence:

Step 1. Confirm you have a valid prescription from a licensed North Dakota prescriber. If you do not have a prescriber relationship, a telehealth consultation is a legal option.

Step 2. Check your insurance formulary. If you have commercial insurance or Medicare Part D, call member services or check the carrier's online drug search tool. Most plans cover generic amlodipine at Tier 1.

Step 3. If uninsured or if your plan does not cover it, download a free GoodRx coupon at GoodRx.com or pull up the RxSaver app before going to the pharmacy. Present it at checkout.

Step 4. Ask for a 90-day supply. The per-month cost drops to approximately $6 to $7 with a coupon on a 90-day fill.

Step 5. If you are on North Dakota Medicaid and the cash price of $8 is a barrier, ask your prescriber to submit a prior authorization. Cite the 2023 AHA/ACC guideline language and the ASCOT-BPLA and ALLHAT trial data as clinical justification.

Step 6. If you have a documented clinical need for a compounded preparation (pediatric dosing, dysphagia, excipient sensitivity), ask your prescriber to send the compound order to a PCAB-accredited 503A pharmacy in North Dakota or one licensed to ship to North Dakota residents.

A 5 mg once-daily dose is the most commonly prescribed starting dose per the FDA prescribing label for amlodipine. Titration to 10 mg once daily is appropriate if blood pressure remains above goal after four weeks.